These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 2260456

  • 1. Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: an interim report on five European studies.
    Johansson G, Sietnieks A, Janssens F, Proesmans W, Vanderschueren-Lodeweyckx M, Holmberg C, Sipilä I, Broyer M, Rappaport R, Albertsson-Wikland K.
    Acta Paediatr Scand Suppl; 1990; 370():36-42; discussion 43. PubMed ID: 2260456
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone treatment in short children with chronic renal failure and after renal transplantation: combined data from European clinical trials. The European Study Group.
    Van Es A.
    Acta Paediatr Scand Suppl; 1991; 379():42-8; discussion 49. PubMed ID: 1815459
    [Abstract] [Full Text] [Related]

  • 3. Effects of two years of growth hormone treatment in short children with renal disease. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Tönshoff B, Dietz M, Haffner D, Tönshoff C, Stöver B, Mehls O.
    Acta Paediatr Scand Suppl; 1991; 379():33-41. PubMed ID: 1815458
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group.
    Fine RN, Kohaut EC, Brown D, Perlman AJ.
    J Pediatr; 1994 Mar; 124(3):374-82. PubMed ID: 8120705
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Factors influencing the response to growth hormone in children with renal disease.
    Rees L, Maxwell H.
    Pediatr Nephrol; 1996 Jun; 10(3):337-9. PubMed ID: 8792400
    [Abstract] [Full Text] [Related]

  • 12. Results of recombinant growth hormone treatment in children with end-stage renal disease on regular hemodialysis.
    Youssef DM.
    Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):755-64. PubMed ID: 22805388
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Haffner D, Wühl E, Schaefer F, Nissel R, Tönshoff B, Mehls O.
    J Am Soc Nephrol; 1998 Oct; 9(10):1899-907. PubMed ID: 9773791
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Growth hormone treatment of growth failure among children with renal transplants.
    Jabs K, Van Dop C, Harmon WE.
    Kidney Int Suppl; 1993 Oct; 43():S71-5. PubMed ID: 8246374
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.